Atherogenic index of plasma as a biomarker of atherogenecity in type 2 diabetes mellitus in Erbil city

Abstract

Background and objective: Atherogenic index of plasma (AIP) is a mathematical method logarithmically ratio between concentrations of triglycerides to HDL-cholesterol, AIP= Log (TG/HDL), so AIP increase with increase triglycerides and reversible with HDL level. The aim of this study is to evaluation the AIP as a stronger biomarker of atherosclerosis among type 2 diabetes mellitus (DM). Methods: This was a cross sectional-study contacted. A total of 65 patients of type 2 diabetic patient group from Laila Qasim Center for Diabetes in Erbil City collection of blood samples from 65 patients of type 2 diabetic patient group from Laila Qasim Center for Diabetes in Erbil City, compared with 50 healthy volunteers (control group). Blood samples were collected into serum separation tube (gel tube) and (K3EDTA) tube, allowed gel tube to clot at room temperature for 5 minutes then centrifuged at 4000 round per minute (rpm). The separated serum was used immediately for biochemical tests and all the laboratory investigation analysis were carried out from 2nd January to 2nd August 2021. Results: The results of this study found that the level of serum glucose, HbA1C, albumin, CRP, and AIP in diabetics were significantly higher than healthy group, while decreasing S. HDL in diabetic patients compare with healthy individuals. Conclusion: The study detected high level of AIP in type 2 DM patients. Accordingly, patients with type 2 DM should be followed up with regular dietary lipid intake, take lipid lowering drugs, with exercise in order to diminish AIP.